Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Neoplasm

Explore clinical trials studying Pancreatic Neoplasm. Study availability and eligibility vary by location and protocol.

51 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Neoplasm trial results

Recruiting

A Study of LY4170156 in Participants With Selected Advanced Solid Tumors

NCT06400472

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +42 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
  • NYU Langone Health - Long Island Mineola, New York, United States
View all 23 locations
View Trial Details
Recruiting

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

NCT04239573

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 424 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

NCT06051695

Conditions
Adenoma, Adnexal Diseases, Bronchial Neoplasms, +61 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Stanford University Stanford, California, United States
View Trial Details
Recruiting

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

NCT05687123

Conditions
Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +14 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Memorial Hospital East Shiloh, Illinois, United States
View Trial Details
Recruiting

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

NCT06807437

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis Daphne, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
View all 118 locations
View Trial Details

Related conditions